e-CBT for Bipolar Disorder

Phase-Based Progress Estimates
Bipolar Disorder+1 Moree-CBT - Behavioral
18 - 55
All Sexes
What conditions do you have?

Study Summary

This trial aims to study the feasibility and effectiveness of e-CBT for treating patients with bipolar II disorder who have residual depressive symptoms.

Eligible Conditions
  • Bipolar Disorder
  • Depression, Bipolar Disorder

Treatment Effectiveness

Study Objectives

3 Primary · 1 Secondary · Reporting Duration: Baseline, week 6, week 12

Week 12
Change in symptoms (Modified Clinical Global Impression Scale for Bipolar Disorder - CGI-BP-M)
Change in symptoms (Montgomery Asberg Depression Rating Scale - MADRS)
Change in symptoms (Young Mania Rating Scale - YMRS)
Week 12 (Post-Treatment)
Differences in personal, social, and cultural factors impacting accessibility to treatment

Trial Safety

Trial Design

2 Treatment Groups

Treatment as Usual
1 of 2
1 of 2

Active Control

Experimental Treatment

80 Total Participants · 2 Treatment Groups

Primary Treatment: e-CBT · No Placebo Group · N/A

Experimental Group · 1 Intervention: e-CBT · Intervention Types: Behavioral
Treatment as UsualNoIntervention Group · 1 Intervention: Treatment as Usual · Intervention Types:
First Studied
Drug Approval Stage
How many patients have taken this drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, week 6, week 12

Who is running the clinical trial?

Queen's UniversityLead Sponsor
336 Previous Clinical Trials
110,868 Total Patients Enrolled
6 Trials studying Bipolar Disorder
397 Patients Enrolled for Bipolar Disorder
Online PsychoTherapy ClinicOTHER
8 Previous Clinical Trials
566 Total Patients Enrolled
Nazanin AlaviPrincipal InvestigatorQueen's University
5 Previous Clinical Trials
386 Total Patients Enrolled

Eligibility Criteria

Age 18 - 55 · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: